uPA/uPAR and SERPINE1 in head and neck cancer: role in tumor resistance, metastasis, prognosis and therapy-Reference-Cited by-同舟云学术

uPA/uPAR and SERPINE1 in head and neck cancer: role in tumor resistance, metastasis, prognosis and therapy

Published:2016-06-30 Issue:35 Volume:7 Page:57351-57366
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Pavón Miguel Angel¹²³,Arroyo-Solera Irene¹³,Céspedes Maria Virtudes¹³,Casanova Isolda¹³,León Xavier³⁴,Mangues Ramón¹³

Affiliation:

1. Grupo d’Oncogènesi i Antitumorals, lnstitut d’Investigacions Biomèdiques Sant Pau (IIB-Sant Pau), Barcelona, Spain

2. Infections and Cancer Unit, Cancer Epidemiology Research Programme, Catalan Institute of Oncology (ICO) and Bellvitge Institute of Biomedical Research (IDIBELL), Barcelona, Spain

3. Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomecidicina (CIBER-BBN), Barcelona, Spain

4. Department of Otorrinolaryngology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrating molecular dynamics simulation with small‐ and wide‐angle X‐ray scattering to unravel the flexibility, antigen‐blocking, and protease‐restoring functions in a hindrance‐based pro‐antibody;Protein Science;2024-08-15

2. Pan‐cancer analysis of SERPINE1 with a concentration on immune therapeutic and prognostic in gastric cancer;Journal of Cellular and Molecular Medicine;2024-07-31

3. Acquired Temozolomide Resistance Instructs Patterns of Glioblastoma Behavior in Gelatin Hydrogels;Advanced Healthcare Materials;2024-07-19

4. 5-Fluorouracil resistance-based immune-related gene signature for COAD prognosis;Heliyon;2024-07

5. Urokinase-Type Plasminogen Activator Receptor (uPAR) in Inflammation and Disease: A Unique Inflammatory Pathway Activator;Biomedicines;2024-05-24